Powell et al. first reported the effects of compounds known to stimulate CFTR trafficking on human β-cells lacking functional KATP currents from CHI patients harboring various ABCC8 mutations (Powell et al., 2011). The gene discussed is ABCC8; the disease is congenital isolated hyperinsulinism.